deucravacitinib
bms
['psoriasis', 'deucrava', 'deucra']
late breaking research at #eadv2022 - deucravacitinib raising the bar for oral therapies in treatment of moderate to severe #psoriasis
Consultant Dermatologist, Adult and Paediatric, @BelfastTrust @UlsterClinic, PhD, skin research, husband to @Hen_OKane, Dad, @manutd ?????